BRD4-TARGETED THERAPY ABBV-744 CLINICAL DATA NO FURTHER A MYSTERY

In Section A, members will obtain various doses and schedules of oral ABBV-744 pill to establish safe dosing routine. Added individuals will probably be enrolled at the determined monotherapy dosign regimen. In Phase B, individuals will get oral ruxolitinib and ABBV-744 is going to be provided as "include-on" therapy. In Phase C, participants will